Founded in Shenzhen.
Established Hunan APT R&D Center.
First CFDA certificate for EP catheters.
CFDA certificate for Ablation catheter.
CE for EP catheters.
Holding Shanghai Hongtong Industrial Co., Ltd.
Since 2016, CE and NMPA for coronary intervention products.
Established Hongkong subsidiary.
APT Medical listed on the Shanghai STAR Exchange.
3D mapping system approved by NMPA.
Established the first overseas subsidiary in Indonesia.
